New approaches to the discovery of treatments for major unmet medical needs
Phenotypic drug discovery (PDD) has lower costs and is showing higher success rates than traditional target-based approaches, improving health outcomes and lowering the cost of new medications - see more. Our multidisciplinary research group is undertaking PDD in areas of cancer, fibrosis (organ failure) and autoimmune disease. Contact Associate Professor Bernard Flynn for more project details.
Enhanced research experiences
All projects in this program are multidisciplinary and involve collaborations from within Monash Institute Pharmaceutical Science and with researchers elsewhere (UniSA, Monash Medicine, University of Melbourne). The student will be primarily responsible for drug synthesis and design. Drug design will be based on structure-activity relationships based on bioactivity data collected by our collaborators.
A rotation program may be available. Please contact Associate Professor Bernard Flynn to discuss.
Depending on student interest, there exists an opportunity to spend a greater period of time with one of the cell biology (phenotypic assay) groups learning new skills relevant chemical-biology.